ALCAM and carcinoma: With univariate Cox regression analysis, in no special type carcinomas, ALCAM overexpression was associated with worse prognosis (OS: HR = 4.32, 95% CI: 1.61–11.56, p = 0.004, and the RFS: HR = 2.47, 95% CI: 1.17–5.22, p = 0.018), while in the multivariate analysis, with stage, nodal status, grade, ER status, the prognostic value of ALCAM expression was borderline, p = 0.050 [24].